DRREDDYBSEDr Reddys Laboratories LtdMinimalNeutral
Announced Wed, 27 May · 21:38 IST

Copies of newspaper publication

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹1320.00
prior close
₹1318.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.0-0.7-2.5-3.3-4.4-3.9-2.8-3.8-4.0+4.5
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories has published a notice about unclaimed dividends from financial year 2018-19 that have remained unpaid for 7 consecutive years. The company is required under Section 124(6) of the Companies Act, 2013 to transfer such dividends and underlying equity shares to the IEPF Authority. Shareholders have until August 30, 2026 to claim their unpaid dividends. The detailed list of affected shareholders is available on the company's website. Individual notices have been sent to shareholders at their latest available addresses. After the deadline, shares will be transferred to IEPF and no claims can be made against the company.

Likely market impact

Routine regulatory compliance notice. Affected shareholders risk losing their unclaimed dividends and shares to IEPF if they do not claim by August 30, 2026. This has no direct impact on the company's stock price or operations but may slightly reduce the number of shares outstanding in the open market.